3-Chloro-2-(3-(trifluoromethyl)phenoxy)pyridine, 97%, 5g

1,3-dioxa-8-azaspiro[4.5]decan-2-one hydrochloride, 95.0%, 250mg

(S)-2-Acetamido-3,3-dimethylbutanoic acid, 97%, 5g

(5-Chloropyridin-2-yl)methanamine, 95.0%, 25g

2-Fluoro-3-(methylsulfonyl)aniline, 98%, 250mg

Plan PLMi 20x/0.40 infinity corrected IOS objective. Working distance 8.8 mm

Wide mouth jars, 500 ml, 89-400, 12 Piece(s)

3,4-Dimethoxybenzhydrol, 97.0%, 25g

3-Bromo-2-ethoxy-5-(trifluoromethyl)pyridine, 95+%, 5g

Methyl 2-(1-methyl-1H-pyrazol-4-yl)acetate, 95.0%, 10g

3-Bromo-5-iodopyridin-2-ol, 95.0%, 10g

4-Fluoro-7-nitro-1H-indazole, 95.0%, 5g

Ethyl 2-(2-azaspiro[3.3]heptan-6-yl)acetate 2,2,2-trifluoroacetate, 98%, 1g